Mitchell Wells
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Mitchell Wells
Non-Executive Director, Company Secretary / Resonance Health
Most Notable Role
Mitchell Wells is an executive director with management and operational experience in the medical technology, resources, and transport industries. He also has extensive international management experience in a number of industries, including as project leader and lawyer for the Anschutz Entertainment Group and The O2 in London, UK.
Mr Wells was managing director of Resonance Health from July 2021 to May 2023, and has been on its board of directors since April 2017. He was also chief operating officer of Amadeus Energy from March 2008 to December 2012 where he worked with the President of the Amadeus US division and was responsible for coordinating the planning, development and implementation of the company’s strategic business plans.
Mr Wells holds a Bachelor of Law, a Bachelor of Commerce, and a Diploma of Aviation.
Mr Wells was managing director of Resonance Health from July 2021 to May 2023, and has been on its board of directors since April 2017. He was also chief operating officer of Amadeus Energy from March 2008 to December 2012 where he worked with the President of the Amadeus US division and was responsible for coordinating the planning, development and implementation of the company’s strategic business plans.
Mr Wells holds a Bachelor of Law, a Bachelor of Commerce, and a Diploma of Aviation.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 536th | Proteomics International Laboratories | 8% | 26% |
| 628th | Resonance Health | 3% | -7% |
| 840th | HITIQ | -7% | |
| 1612th | Nuheara | -60% | -44% |
| 1835th | Emyria | -78% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 123rd |  | Resonance Health | $4.5m |
| 130th | | Emyria | $3.8m |
| 131st | | Nuheara | $3.8m |
| 135th |  | HITIQ | $3.2m |
| 136th | | Proteomics International Laboratories | $3.2m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Board Moves June 23, 2023 | 23 Jun 2023 |
| NEW ROLE: Non-Executive Director, Company Secretary, Resonance Health | 23 Jun 2023 |
| NEW ROLE: Managing Director, Executive Director, Resonance Health | 04 Jun 2021 |
| REMUNERATION UPDATE: Non-Executive Director, Company Secretary since 2021, Resonance Health | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Company Secretary since 2021, Resonance Health | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Company Secretary since 2021, Resonance Health | 30 Jun 2020 |
